Scientific Session
Tomas Mustelin, MD, PhD
University of Washington
Seattle, WA, United States
Disclosure(s): Bristol-Myers Squibb(BMS): Consultant (Ongoing); Cugene: Advisor or Review Panel Member (Ongoing), Consultant (Ongoing); MiroBio: Advisor or Review Panel Member (Terminated, April 30, 2023); QiLu Biopharma: Consultant (Ongoing); ROME Therapeutics: Advisor or Review Panel Member (Ongoing)